REGENEREX PHARMA, INC. Common Stock Shares Outstanding

Quick Answer

REGENEREX PHARMA, INC. reported Common Stock Shares Outstanding of 281.07 million shares for the year ending 2025.

  • REGENEREX PHARMA, INC. showed an increase of +1.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from REGENEREX PHARMA, INC.'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2010 to 2025), REGENEREX PHARMA, INC.'s Common Stock Shares Outstanding has grown by 292,682.2%.
  • Historical annual values: Fiscal year 2025: 281.07 million shares | Fiscal year 2024: 278.23 million shares | Fiscal year 2023: 277.11 million shares | Fiscal year 2022: 277.11 million shares | Fiscal year 2021: 127.11 million shares | Fiscal year 2020: 127.11 million shares | Fiscal year 2019: 127.11 million shares | Fiscal year 2018: 127.11 million shares | Fiscal year 2017: 156.06 million shares | Fiscal year 2014: 156.41 million shares | Fiscal year 2013: 151.12 million shares | Fiscal year 2012: 149.08 million shares | Fiscal year 2011: 171.02 million shares | Fiscal year 2010: 96,000 shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: